Youwei Lin
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Ofatumumab for multiple sclerosis with disability accumulation.
Journal: Journal of the neurological sciences
Published: August 23, 2024
High frequency of circulating non-classical monocytes is associated with stable remission in relapsing-remitting multiple sclerosis.
Journal: Immunological medicine
Published: March 28, 2024
CD11chigh B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 13, 2024
Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: August 28, 2023
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
Journal: Journal of autoimmunity
Published: May 25, 2023
Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 12, 2023
Resident Memory-like CD8+ T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 08, 2023
Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial.
Journal: JMIR research protocols
Published: February 23, 2023
Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis.
Journal: Frontiers in immunology
Published: December 29, 2022
First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis.
Journal: Therapeutic advances in neurological disorders
Published: September 08, 2022
Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: March 25, 2022
Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2021
Last Updated: 09/26/2026